NCI awards $1.5M for development of companion Dx test for melanoma

09/26/2013 | GenomeWeb Daily News (free registration)

The National Cancer Institute has awarded BioMarker Strategies a $1.5 million grant to advance the development of its PathMap test, a companion diagnostic assay for melanoma. The company also will use the grant to finance its efforts to validate the assay in human clinical specimens.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID